Skip to main content

Table 1 Demographic and clinical characteristics of patients with febrile neutropenia

From: Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country

Variable

n (%)

Age (years), mean ± SD

40.2 ± 16

Sex

 

 Male

98 (65.3)

 Female

52 (34.7)

Presence of CVC

 

 Yes

47 (31.3)

 No

103 (68.7)

Comorbidities

 

 Diabetes mellitus

21 (14)

 Hypertension

15 (10)

 COPD

4 (2.6)

 Ischemic heart disease

8 (5.3)

 Osteoarthritis

1 (0.7)

 Depression

1 (0.7)

 Hepatitis B

5 (3.3)

 PCOS

1 (0.7)

 CHF

1 (0.7)

 Epilepsy

1 (0.7)

 Atrial fibrillation

1 (1.3)

 Other arrythmias

2 (1.3)

 Thrombophilia

1 (0.7)

 Hypothyroidism

1 (0.7)

 Ulcerative colitis

1 (0.7)

 Liver cirrhosis

1 (0.7)

 Primary sclerosing cholangitis

1 (0.7)

Focus of fever

 

 None identified

108 (72)

 BSI

7 (4.6)

 Cellulitis

6 (4)

 Osteomyelitis

1 (0.7)

 Colitis

12 (8)

 Pneumonia

8 (5.3)

 Bronchitis

1 (0.7)

 Meningoencephalitis

1 (0.7)

 Buccal ulcer

1 (0.7)

 Perianal abscess

2 (1.3)

 Mucositis

1 (0.7)

 Jaw infection

1 (0.7)

 Intraabdominal infection

1 (0.7)

Duration of fever (days), median and IQR

2 (1–4)

Duration of neutropenia (days), median and IQR

7 (4–14)

Culture positive

 

 Yes

49 (32.7)

 No

101 (67.3)

Polymicrobial infection (among positive cultures)

 

 Yes

13 (26.5)

 No

34 (73.5)

  1. CVC, central venous catheters; SD, slandered deviation; COPD, chronic obstructive pulmonary disease; CHF, congestive heart failure; BSI, bloodstream infection; IQR, interquartile range